| Dr Pradeep Kumar, MD | |
|
4310 James Casey St, Suite 4a, Austin, TX 78745-1120 | |
| (512) 448-4588 | |
| (512) 445-4511 |
| Full Name | Dr Pradeep Kumar |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 33 Years |
| Location | 4310 James Casey St, Austin, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093790537 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | J2268 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St David's South Austin Medical Center | Austin, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Austin Gastroenterology Pllc | 9739174954 | 73 |
News Archive
A team of researchers from the USA and China have engineered a receptor-binding domain (RBD) that they claim improves the immunogenicity of multivalent SARS-CoV-2 vaccines. Their study, which was released on the bioRxiv* in November 2020, may help advance even more efficacious SARS-CoV-2 vaccine candidates in the future.
Every day, more than 20 percent of the U.S. population experiences the painful burning symptoms of gastroesophageal reflux disease (GERD). For these 20 million Americans, the first line of defense is medication. To find a long-term, permanent solution for this nagging condition, the Center for the Future of Surgery at UC San Diego Medical Center is leading a multicenter clinical trial to test the safety and effectiveness of a new incisionless GERD treatment.
The Assisted Living Federation of America, today hosted a meeting of 140 executives interested in advancing excellence in senior living. The day-long event at National Harbor, Maryland offered executives briefings on topics shaping their businesses today and peer discussions groups to help find answers to some of the big shared questions on their minds.
Aeterna Zentaris Inc. today announced plans to conduct a new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency ("AGHD"), as well as a dedicated thorough QT study to evaluate the effect of Macrilen on myocardial repolarization.
A new study by Georgetown University credits the health law as having a 'key role' in the increase in children's health insurance coverage.
› Verified 7 days ago
| Entity Name | Austin Gastroenterology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316998016 PECOS PAC ID: 9739174954 Enrollment ID: O20040417000145 |
News Archive
A team of researchers from the USA and China have engineered a receptor-binding domain (RBD) that they claim improves the immunogenicity of multivalent SARS-CoV-2 vaccines. Their study, which was released on the bioRxiv* in November 2020, may help advance even more efficacious SARS-CoV-2 vaccine candidates in the future.
Every day, more than 20 percent of the U.S. population experiences the painful burning symptoms of gastroesophageal reflux disease (GERD). For these 20 million Americans, the first line of defense is medication. To find a long-term, permanent solution for this nagging condition, the Center for the Future of Surgery at UC San Diego Medical Center is leading a multicenter clinical trial to test the safety and effectiveness of a new incisionless GERD treatment.
The Assisted Living Federation of America, today hosted a meeting of 140 executives interested in advancing excellence in senior living. The day-long event at National Harbor, Maryland offered executives briefings on topics shaping their businesses today and peer discussions groups to help find answers to some of the big shared questions on their minds.
Aeterna Zentaris Inc. today announced plans to conduct a new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency ("AGHD"), as well as a dedicated thorough QT study to evaluate the effect of Macrilen on myocardial repolarization.
A new study by Georgetown University credits the health law as having a 'key role' in the increase in children's health insurance coverage.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pradeep Kumar, MD Po Box 10597, Austin, TX 78766-1597 Ph: (512) 485-5878 | Dr Pradeep Kumar, MD 4310 James Casey St, Suite 4a, Austin, TX 78745-1120 Ph: (512) 448-4588 |
News Archive
A team of researchers from the USA and China have engineered a receptor-binding domain (RBD) that they claim improves the immunogenicity of multivalent SARS-CoV-2 vaccines. Their study, which was released on the bioRxiv* in November 2020, may help advance even more efficacious SARS-CoV-2 vaccine candidates in the future.
Every day, more than 20 percent of the U.S. population experiences the painful burning symptoms of gastroesophageal reflux disease (GERD). For these 20 million Americans, the first line of defense is medication. To find a long-term, permanent solution for this nagging condition, the Center for the Future of Surgery at UC San Diego Medical Center is leading a multicenter clinical trial to test the safety and effectiveness of a new incisionless GERD treatment.
The Assisted Living Federation of America, today hosted a meeting of 140 executives interested in advancing excellence in senior living. The day-long event at National Harbor, Maryland offered executives briefings on topics shaping their businesses today and peer discussions groups to help find answers to some of the big shared questions on their minds.
Aeterna Zentaris Inc. today announced plans to conduct a new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency ("AGHD"), as well as a dedicated thorough QT study to evaluate the effect of Macrilen on myocardial repolarization.
A new study by Georgetown University credits the health law as having a 'key role' in the increase in children's health insurance coverage.
› Verified 7 days ago
Dr. Tatiana B. Jacobson, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5656 Bee Caves Rd. Bldg C Ste. 102, Austin, TX 78746 Phone: 512-323-5465 Fax: 512-327-1390 | |
Preeti Venkatraman, M.B.B.S. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 601 E 15th St, Austin, TX 78701 Phone: 512-324-7000 | |
Pritesh Harish Gandhi, M.D., M.P.H. Gastroenterology Medicare: Medicare Enrolled Practice Location: 1101 Camino La Costa, Austin, TX 78752 Phone: 512-684-1832 | |
Dr. Joshua Lane Davis, D.O. Gastroenterology Medicare: Medicare Enrolled Practice Location: 1004 W 32nd St Unit 300, Austin, TX 78705 Phone: 512-324-3440 | |
Dr. Analicia Alvarado, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1500 Red River St, Austin, TX 78701 Phone: 512-324-7000 | |
Dr. Grace Marie Grant-jennings, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7000 North Mopac, Suite # 420, Austin, TX 78731 Phone: 512-482-0045 Fax: 512-476-9892 | |
Dr. Debra Ann Patt, MD, MPH Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6204 Balcones Dr, Austin, TX 78731 Phone: 512-427-9400 Fax: 512-342-2723 |